Abingdon Health Income Statement

Financials in millions GBP. Fiscal year is July - June.

Millions GBP. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Revenue	6.82	6.14	4.05	2.84	11.62	5.24
Revenue Growth (YoY)	27.60%	51.67%	42.68%	-75.60%	121.93%	-
Cost of Revenue	3.23	2.46	1.97	6.43	7.48	1.15
Gross Profit	3.59	3.68	2.08	-3.59	4.14	4.09
Selling, General & Admin	5.55	5.07	5.22	6.65	7.55	3.37
Other Operating Expenses	-0.11	-0.26	-0.25	-0.24	-0.15	-0.13
Operating Expenses	5.96	5.29	5.69	8.27	9.52	3.87
Operating Income	-2.37	-1.61	-3.61	-11.87	-5.37	0.22
Interest Expense	-0.06	-0.05	-0.07	-0.07	-0.23	-0.07
Interest & Investment Income	0.05	0.03	0.09	0	-	0
Other Non Operating Income (Expenses)	-0	-0	0.39	-	-	-
EBT Excluding Unusual Items	-2.38	-1.63	-3.21	-11.93	-5.61	0.15
Merger & Restructuring Charges	0.11	-	-0.16	-0.2	-0.19	-
Impairment of Goodwill	-	-	-	-0.76	-	-3.13
Asset Writedown	-0.36	-	-0.09	-6.43	-	-0.4
Legal Settlements	-	-	-	-1.59	-	-
Other Unusual Items	-0.18	0.23	-0.12	-0.69	-1.16	-
Pretax Income	-2.81	-1.4	-3.57	-21.59	-6.95	-3.38
Income Tax Expense	-0.23	-0.13	-0.11	-0.33	0.02	-0
Net Income	-2.59	-1.27	-3.47	-21.26	-6.97	-3.37
Net Income to Common	-2.59	-1.27	-3.47	-21.26	-6.97	-3.37
Shares Outstanding (Basic)	330	305	304	292	278	-
Shares Outstanding (Diluted)	330	305	304	292	278	-
Shares Change (YoY)	8.55%	0.23%	4.26%	4.89%	-	-
EPS (Basic)	-0.01	-0.00	-0.01	-0.07	-0.03	-
EPS (Diluted)	-0.01	-0.00	-0.01	-0.07	-0.03	-
Free Cash Flow	-2.68	-1.69	0.84	-8.42	-19.64	0.45
Free Cash Flow Per Share	-0.01	-0.01	0.00	-0.03	-0.07	-
Gross Margin	52.57%	59.97%	51.30%	-126.70%	35.66%	78.05%
Operating Margin	-34.80%	-26.18%	-89.27%	-418.52%	-46.24%	4.15%
Profit Margin	-37.94%	-20.72%	-85.76%	-749.98%	-60.02%	-64.45%
Free Cash Flow Margin	-39.26%	-27.61%	20.72%	-297.04%	-169.02%	8.50%
EBITDA	-2.03	-1.25	-2.98	-10.59	-4.94	0.28
EBITDA Margin	-29.83%	-20.36%	-73.75%	-	-42.54%	5.31%
D&A For EBITDA	0.34	0.36	0.63	1.28	0.43	0.06
EBIT	-2.37	-1.61	-3.61	-11.87	-5.37	0.22
EBIT Margin	-34.80%	-26.18%	-89.27%	-	-46.24%	4.15%

Updated Oct 8, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.